IGC PHARMA INC IGC
COM NEW · Common Stock · CUSIP 45408X308
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersPotomac, MD
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 92.9m as of 2025-10-30, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $0.28. Options: 1 managers hold calls ($1.2k notional), 0 hold puts (—).
Trends to Q4 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 27 |
| Q4 2022 | 27 |
| Q1 2023 | 24 |
| Q2 2023 | 24 |
| Q3 2023 | 28 |
| Q4 2023 | 26 |
| Q1 2024 | 26 |
| Q2 2024 | 26 |
| Q3 2024 | 24 |
| Q4 2024 | 31 |
| Q1 2025 | 26 |
| Q2 2025 | 29 |
| Q3 2025 | 35 |
| Q4 2025 | 30 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2024 | 9 | 11 |
| Q2 2024 | 9 | 12 |
| Q3 2024 | 11 | 6 |
| Q4 2024 | 13 | 9 |
| Q1 2025 | 7 | 11 |
| Q2 2025 | 11 | 7 |
| Q3 2025 | 17 | 6 |
| Q4 2025 | 8 | 14 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q1 2025 | $0 | $0 | — |
| Q2 2025 | $0 | $0 | — |
| Q3 2025 | $8.2k | $0 | 0.00 |
| Q4 2025 | $1.2k | $0 | 0.00 |
Biggest buyers
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Added | +141.0k |
| STATE STREET CORP | Added | +40.6k |
| UBS Group AG | Added | +16.8k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +8.0k |
| Tower Research Capital LLC (TRC) | Added | +4.6k |
| JONES FINANCIAL COMPANIES LLLP | New | +110 |
| Root Financial Partners, LLC | New | +100 |
| Triumph Capital Management | New | +2 |
Biggest sellers
| CITADEL ADVISORS LLC | Reduced | -350.2k |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | -299.3k |
| Virtu Financial LLC | Sold out | -89.5k |
| HRT FINANCIAL LP | Sold out | -60.3k |
| TWO SIGMA SECURITIES, LLC | Sold out | -35.0k |
| GSA CAPITAL PARTNERS LLP | Sold out | -27.8k |
| Baader Bank Aktiengesellschaft | Sold out | -14.0k |
| THOMPSON DAVIS & CO., INC. | Sold out | -10.0k |
| XTX Topco Ltd | Reduced | -5.7k |
| BANK OF AMERICA CORP /DE/ | Reduced | -2.1k |
Biggest calls
| SIMPLEX TRADING, LLC | New | $1.2k4.3k shares |
Biggest puts
| None |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Insider purchases and sales in Q4 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 1 | $200.0k | 0 | — | — |
| Q4 2024 | 0 | — | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 0 | — | 0 | — | — |
| Q4 2025 | 0 | — | 0 | — | — |
None reported in Q4 2025.
Holders, Q4 2025
| Manager | Shares | Change |
|---|---|---|
| VANGUARD GROUP INC 0.00% of their portfolio | 1.1m $322.9k | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 919.6k $258.8k | Reduced -299.3k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 860.5k $242.2k | Added +8.0k |
| BlackRock, Inc. 0.00% of their portfolio | 703.8k $198.0k | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 277.6k $78.1k | Reduced -350.2k |
| STATE STREET CORP 0.00% of their portfolio | 200.8k $56.5k | Added +40.6k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 155.0k $43.6k | Added +141.0k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 113.4k $31.9k | Unchanged |
| DEARBORN PARTNERS LLC 0.00% of their portfolio | 84.4k $23.8k | Unchanged |
| LAWOOD & CO 0.02% of their portfolio | 75.0k $21.1k | First filing |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 65.5k $18.4k | Unchanged |
| Fisher Asset Management, LLC 0.00% of their portfolio | 43.4k $12.2k | Unchanged |
| TRUIST FINANCIAL CORP 0.00% of their portfolio | 36.7k $10.3k | Unchanged |
| COMMONWEALTH EQUITY SERVICES, LLC 0.00% of their portfolio | 33.3k $9.4k | Reduced -1.6k |
| XTX Topco Ltd 0.00% of their portfolio | 28.3k $8.0k | Reduced -5.7k |
| T3 Companies, LLC 0.01% of their portfolio | 20.0k $5.6k | First filing |
| UBS Group AG 0.00% of their portfolio | 19.9k $5.6k | Added +16.8k |
| MORGAN STANLEY 0.00% of their portfolio | 17.7k $5.0k | Unchanged |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 14.4k $4.0k | Added +4.6k |
| GROUP ONE TRADING LLC 0.00% of their portfolio | 7.2k $2.0k | Unchanged |
| Geneos Wealth Management Inc. 0.00% of their portfolio | 3.0k $840 | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 1.8k $508 | Reduced -2.1k |
| CIBC Private Wealth Group LLC 0.00% of their portfolio | 655 $184 | Unchanged |
| Caitlin John, LLC 0.00% of their portfolio | 200 $56 | Unchanged |
| JONES FINANCIAL COMPANIES LLLP 0.00% of their portfolio | 110 $31 | New |
| Hurley Capital, LLC 0.00% of their portfolio | 100 $28 | Unchanged |
| Root Financial Partners, LLC 0.00% of their portfolio | 100 $28 | New |
| Farther Finance Advisors, LLC 0.00% of their portfolio | 100 $28 | Unchanged |
| DHJJ Financial Advisors, Ltd. 0.00% of their portfolio | 80 $23 | Unchanged |
| Triumph Capital Management 0.00% of their portfolio | 2 $1 | New |